MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 174 participants.
Also called NCT03705312
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 174 participants
- Sponsor
- Registry
-
NCT03705312
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Unknown status
Technical summary
Registry record NCT03705312. Randomized; single masking; primary purpose treatment. Start 2019-02-22 (actual); primary completion 2021-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR
- Acronym
- EVOLVE-MR
- Condition
- Mitral Regurgitation
- Condition
- Heart Failure
- Condition
- Mitral Valve Regurgitation Due to Cardiomyopathy (Disorder)
- Intervention (Device)
- Transcatheter mitral valve repair
- Intervention (Other)
- Guideline-directed medical therapy
- Lead sponsor
- Montreal Heart Institute
- Collaborator
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct03705312- Content hash
613acca208a752bc4b55d0ece9a387ffc6eebd26d63c4c2a72be53b2412d170b